This week, Luis is joined by Dr. Ashlan Kunz-Coyne to discuss some of the newest antibiotics for urinary tract infections (UTIs). They explore why extended-spectrum beta-lactamases (ESBLs) are a growing concern, the impact of E. coli sequence type 131, and where new agents like cefepime–enmetazobactam, sulopenem, and tebipenem fit into treatment. The conversation also highlights clinical data, stewardship considerations, and how the infectious diseases and microbiology communities can work together to preserve these options. Plus, Dr. Kunz-Coyne reveals her favorite bug—Stenotrophomonas maltophilia—and why it’s unlike any other.

 

 Link to sulopenem episode: https://directory.libsyn.com/episode/index/id/35868135

 

Check out the website: https://www.letstalkmicro.com/

Questions? Feedback? Send those to [email protected]

Want to support the podcast? Here's how:

Venmo: https://venmo.com/u/letstalkmicro

Buy me a Ko-fi: https://ko-fi.com/letstalkmicro